FDA Recalls Some Valsartan Medicines Due to Impurity FDA Recalls Some Valsartan Medicines Due to Impurity

Three companies are recalling several drug products containing valsartan due to the presence of N-nitrosodimethylamine, which is classified as a probable human carcinogen.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Alert Source Type: news